1. Medtech Insight

Financing Quarterly Statistics: Q1 Highlights Include 3 Medtech And 7 IVD IPOs

A Look At Financing Activity Across Medical Device And In Vitro Diagnostics Industries, January-March 2021

 
• By Deanna Kamienski and Maureen Riordan

To open the year, medical device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $7bn.

MT-Money-Flow_1200x675

First quarter 2021 device financing reached $2.8bn, a sharp decline from the fourth quarter of 2020’s $4.2bn. The follow-on public offering (FOPO) category made up the most, accounting for $780m, or 28%, of the first-quarter total, followed by VC financings, which brought in an aggregate $736m, or 27% of the first-quarter financing dollars.

During the first quarter, three device players completed IPOs that together totaled $493m, making up 18% of the quarter’s aggregate financing. This group includes Chinese device start-up CardioFlow, which netted

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business

LSX Europe: Women’s Health Education Is The Key For Unlocking VC Investment

 
• By Natasha Barrow

Flo Health was the first femtech unicorn to be valued at over $1bn. But the company faced 49 investment rejections before reaching that status, Anna Klepchukova, the company’s chief medical officer, told the LSX World Congress Europe. THENA Capital’s Esther Reynal de St Michel Richardot talked through the firm’s gender-smart investment strategy.

Synchron And Apple Team Up To Use ‘Mind-Thought Connection’ To Control iPhones, iPads

 
• By Marion Webb

Apple and Synchron are teaming up to develop technologies that will one day allow people who can’t use their hands or voice to control iPhones, iPads and other Apple devices by using only their thoughts.

Abbott’s FreeStyle Libre CGM Reduces Cardiovascular Disease-Related Hospitalization

 
• By Natasha Barrow

The REFLECT studies showed a 78% reduction in cardiovascular disease-related hospitalization for people living with type 1 diabetes with prior low blood sugar episodes.